The evidence for rapamycin as a longevity drug in healthy adults is insufficient

Current clinical trials show limited and inconsistent evidence for lifespan benefits of rapamycin in healthy populations.

From the articleRapamycin Shows Limited Evidence for Longevity Benefits in Healthy AdultsAlso in What is the clinical evidence to support off-label rapamycin therapy in healthy adults?